ABSA: C.DIFF GLP Study

This paper addresses the issues of getting a hospital disinfectant approved by the EPA, some of the challenges encountered and results achieved for a number of hospital related pathogens including MRSA, Pseudomonas sp., H1N1, etc. using a novel approach. The paper also addresses the differences between hands-free and wipes technologies, sprays, and their approval pathways.

The paper presents the results from Good Laboratory Practice Studies (GLP) submitted to EPA for a novel technology using The SteraMistTM Surface and Environmental systems. SteraMistTM Binary Ionization Technology® (BITTM), (TOMI, Beverly Hills, CA), converts a 7.8% hydrogen peroxide solution into a Hydroxyl Radical mist. This EPA registered solution is passed through an atmospheric cold plasma arc where activation occurs.

Complete the form below to download the white paper.